Cargando…
Effects of angiotensin receptor‐neprilysin inhibitor on insulin resistance in patients with heart failure
AIMS: Although the haemodynamic effects of angiotensin receptor‐neprilysin inhibitor (ARNI) on patients with heart failure have been demonstrated, the effect on glucose metabolism has not been fully elucidated. We retrospectively investigated the effect of ARNI on abnormal glucose metabolism in pati...
Autores principales: | Kashiwagi, Yusuke, Nagoshi, Tomohisa, Kimura, Haruka, Tanaka, Yoshiro, Oi, Yuhei, Inoue, Yasunori, Ogawa, Kazuo, Kawai, Makoto, Yoshimura, Michihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192229/ https://www.ncbi.nlm.nih.gov/pubmed/36942494 http://dx.doi.org/10.1002/ehf2.14352 |
Ejemplares similares
-
Heart Failure Treatments Such As Angiotensin Receptor/Neprilysin Inhibitor Improve Heart Failure Status and Glucose Metabolism
por: Kashiwagi, Yusuke, et al.
Publicado: (2022) -
Close linkage between blood total ketone body levels and B-type natriuretic peptide levels in patients with cardiovascular disorders
por: Kashiwagi, Yusuke, et al.
Publicado: (2021) -
Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure
por: Takahashi, Hirotake, et al.
Publicado: (2021) -
URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice
por: Tanaka, Yoshiro, et al.
Publicado: (2021) -
Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity
por: Yoshii, Akira, et al.
Publicado: (2019)